Medicine Matters podcasts

Follow Medicine Matters podcasts
Share on
Copy link to clipboard

Interviews with clinical experts, discussing key issues in diabetes, oncology, and rheumatology.

Springer Healthcare

  • Nov 24, 2020 LATEST EPISODE
  • every other week NEW EPISODES
  • 16m AVG DURATION
  • 25 EPISODES


Search for episodes from Medicine Matters podcasts with a specific topic:

Latest episodes from Medicine Matters podcasts

Supporting people with diabetes in the pandemic (with Michael Vallis)

Play Episode Listen Later Nov 24, 2020 19:02


Health psychologist Michael Vallis, associate professor of family medicine at Dalhousie University in Halifax, Canada, discusses the psychosocial impact of the pandemic on people with diabetes, and how healthcare professionals can identify and support those who are struggling. Find more on Medicine Matters diabetes

World Diabetes Day 2020: Why nurses make the difference (with Lori Berard and Sharon Tovey)

Play Episode Listen Later Nov 10, 2020 14:49


In recognition of World Diabetes Day 2020 and the WHO “International Year of the Nurse and the Midwife” Sharon Tovey joins Editorial Board member Lori Berard to compare and contrast how nurses are making the difference to people with diabetes in the UK and North America, respectively. Find more on Medicine Matters diabetes

EASD 2020: Highlights from the Editorial Board (with Sanjay Kalra, John Wilding and Lori Berard)

Play Episode Listen Later Oct 7, 2020 39:06


Sanjay Kalra, John Wilding and Lori Berard from the Medicine Matters diabetes Editorial Board reflect on their research highlights from this year’s virtual 56th EASD Annual Meeting. Find more on Medicine Matters diabetes

Why psychosocial care matters: Disengagement with diabetes (with Bill Polonsky)

Play Episode Listen Later Oct 4, 2020 19:07


In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. We welcome back Professor Bill Polonsky, from the University of California at San Diego, USA. This time he is addressing disengagement with diabetes – the scale of the problem, why it is so critical yet good data remain so elusive, and what healthcare providers can do to encourage people with diabetes to engage with their disease management. Find more on Medicine Matters diabetes

Why psychosocial care matters: Optimal medication taking in diabetes (with Kirsty Winkley)

Play Episode Listen Later Sep 30, 2020 24:50


In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. For this episode, we are joined by Dr Kirsty Winkley, diabetes nurse and health psychologist from King’s College London, UK, to discuss why people with diabetes can find it so challenging to take medications optimally and consistently, and what healthcare providers can do to help. Find more on Medicine Matters diabetes

Why psychosocial care matters: Working with people using diabetes technology (with Thomas Kubiak)

Play Episode Listen Later Sep 16, 2020 16:14


In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. This episode features Professor Thomas Kubiak, from Johannes Gutenberg University, talking about the psychological considerations necessary for working with people using technology to manage their diabetes. Find more on Medicine Matters diabetes

Why psychosocial care matters: The psychological impact of hypoglycemia (with Christel Hendrieckx)

Play Episode Listen Later Sep 8, 2020 22:46


In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. In this episode, Dr Christel Hendrieckx, from the Australian Centre for Behavioural Research in Diabetes, at Deakin University in Melbourne, discusses the psychological impact of hypoglycemia in people with diabetes. Find more on Medicine Matters diabetes

Why psychosocial care matters: Diabetes distress (with William Polonsky)

Play Episode Listen Later Aug 24, 2020 15:48


In this series of podcasts, we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes study group by taking a look at some of the most important and emerging topics within this field. This episode features Professor William Polonsky, from the University of California at San Diego, discussing how diabetes distress affects the wellbeing and glucose management of people with diabetes, and what healthcare professionals can do to help. Find more on Medicine Matters diabetes

Why psychosocial care matters: The role of the PSAD (with Frank Snoek)

Play Episode Listen Later Aug 24, 2020 19:38


This year is the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes (PSAD) study group. Marking the occasion, the 'Why psychosocial care matters' podcast series will explore important and emerging topics with experts in psychosocial aspects of diabetes. To launch the series, we talk to Professor Frank Snoek, founder and first Chairperson of the study group, about its history and achievements, and the changing profile of psychosocial research in diabetes care. Find more on Medicine Matters diabetes

The DiRECT approach to weight loss: Efficacious and pragmatic (with Alison Barnes)

Play Episode Listen Later Jul 28, 2020 25:35


The DiRECT trial ran counter to received wisdom by advocating a very-low-calorie, total-meal-replacement diet as a means not just of weight loss but also of weight maintenance for people with type 2 diabetes. Trial dietitian Alison Barnes (Newcastle University, UK) speaks of her initial skepticism, and describes how the diet worked as a pragmatic way for people with type 2 diabetes to achieve weight loss and maintain it long term. Find more on Medicine Matters diabetes

ADA 2020 Goes Virtual! Editorial Board conference highlights (with Lori Berard, John Wilding, & Sanjay Kalra

Play Episode Listen Later Jun 23, 2020 34:18


Owing to the COVID-19 pandemic, the 80th ADA Scientific Sessions was an entirely online event. In this podcast, editorial board members Lori Berard, John Wilding, and Sanjay Kalra reflect on this novel format and discuss their scientific highlights. Find more on Medicine Matters diabetes

Closed-loop insulin delivery research update from ADA 2020 (with Rayhan Lal)

Play Episode Listen Later Jun 23, 2020 18:55


Following the wealth of artificial pancreas research presented at this year’s ADA Scientific Sessions, Rayhan Lal (Stanford University, California, USA) reflects on the current status of the field, and suggests where researchers and manufacturers should now be placing their focus for the greatest benefit of people with diabetes. Find more on Medicine Matters diabetes

Is oral semaglutide a game changer or nice-to-have for type 2 diabetes? (with Neil Skolnik)

Play Episode Listen Later Apr 29, 2020 12:27


Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College in Philadelphia, Pennysylvania, USA, gives his view and outlines key considerations for the use of this new medication as part of a shared decision-making process with people who have type 2 diabetes. For more of the latest news and insights on diabetes medications, visit: https://bit.ly/MMd_medications

Alison Evert on the ADA consensus report on nutrition therapy for adults with diabetes or prediabetes

Play Episode Listen Later Dec 11, 2019 22:18


The first author on the American Diabetes Association's 2019 consensus on nutrition therapy for adults with diabetes or prediabetes talks through the update and what it means for educators, practitioners and patients. The full consensus document is available from Diabetes Care. Find more on Medicine Matters diabetes

Peer mentoring for teens with type 1 diabetes (with Ashby Walker)

Play Episode Listen Later Nov 11, 2019 9:13


Medical sociologist Ashby Walker, from the University of Florida in Gainesville, talks about a mentoring scheme pairing college students and teenagers who have type 1 diabetes - to the benefit of both. Find more on Medicine Matters diabetes

How was it for you? The experts discuss EASD 2019 (with John Wilding, Rick Lambert, and Lori Berard)

Play Episode Listen Later Sep 24, 2019 22:06


Listen to our clinical advisors discussing their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial. Find more on Medicine Matter diabetes More from EASD 2019

REWIND, DECLARE, and high-risk diabetes patients (with Kamlesh Khunti)

Play Episode Listen Later Jul 2, 2019 9:06


How will the findings of the REWIND trial and the DECLARE-TIMI 58 renal outcomes analysis affect treatment decisions for high-risk diabetes patients without overt cardiovascular disease? medwireNews asks Kamlesh Khunti. Find more on Medicine Matters diabetes

Nephrologist expert commentary: The CREDENCE trial (with Andrew Frankel)

Play Episode Listen Later Jun 24, 2019 4:06


Andrew Frankel, Consultant Physician and Nephrologist at Imperial College Healthcare NHS Trust, tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 17, 2019.

Barriers to insulin: Management in type 2 diabetes patients (with Lori Berard)

Play Episode Listen Later Jun 24, 2019 11:54


Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on August 1, 2018.

UK nutrition guidelines: A fresh approach (with John Wilding and Pamela Dyson)

Play Episode Listen Later Jun 24, 2019 9:44


Board members John Wilding and Pamela Dyson talk about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on March 19, 2018.

SGLT2 inhibitors: The story so far (with John Wilding)

Play Episode Listen Later Jun 24, 2019 14:08


Editorial board member John Wilding discusses the lessons for healthcare professionals from the SGLT2 inhibitor cardiovascular outcome trials about the benefits and drawbacks of the medication class. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on September 8, 2017.

Dissecting the CANVAS trial (with Carol Wysham and Lori Berard)

Play Episode Listen Later Jun 24, 2019 11:18


Listen to CANVAS investigators Carol Wysham and Lori Berard discussing the efficacy and safety findings of the trials. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on August 8, 2017.

Primary care expert commentary: The CREDENCE trial (with Kevin Fernando)

Play Episode Listen Later Apr 23, 2019 4:44


Kevin Fernando, GP Partner at the North Berwick Health Centre near Edinburgh, UK, talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 17, 2019.

Researcher comment: The CREDENCE trial (with Vlado Perkovic)

Play Episode Listen Later Apr 23, 2019 6:52


Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 15, 2019.

Barriers to insulin: Initiation in type 2 diabetes patients (with Lori Berard)

Play Episode Listen Later Feb 18, 2019 9:01


Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on June 6, 2018.

Claim Medicine Matters podcasts

In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

Claim Cancel